The FTC Study on Barriers to Entry in the Pharmaceutical Marketplace
Full Committee Hearing

Full Committee
Date: Tuesday, June 17, 2003
Time: 10:00 AM

Agenda


NOTICE OF RESCHEDULED HEARING

The hearing scheduled by the Senate Committee on the Judiciary for Tuesday, April 29, 2003 on "The FTC Study on Barriers to Entry in the Pharmaceutical Marketplace," has been rescheduled for Tuesday, June 17, 2003 at 10:00 a.m. in Dirksen Room 226 .

By order of the Chairman

Member Statements


  1. Senator Orrin G. Hatch (R - UT)
  2. Senator Patrick Leahy (D - VT)

Witnesses


Panel I

  1. The Honorable Timothy J. Muris, Esq.
    Chairman
    Federal Trade Commission
    Washington , DC
  2. Mr. Sheldon T. Bradshaw, Esq.
    Deputy Assistant Attorney General, Office of Legal Counsel
    Department of Justice
    Washington , DC
  3. Mr. Dan Troy, Esq.
    Chief Counsel for Food and Drugs
    Food and Drug Administration
    Rockville , MD

Panel II

  1. The Honorable Howard M. Metzenbaum, Esq.
    Former United States Senator [D-OH]
    Chairman, Consumer Federation of America
    Washington , DC
  2. Ms. Kathleen Jaeger, Esq.
    President and CEO
    Generic Pharmaceutical Association
    Washington, D.C.
  3. Mr. Bruce Kuhlik, Esq.
    General Counsel
    Pharmaceutical Research and Manufacturers of America
    Washington , DC